Title : Case Report: Humanized Selective CD19CAR-T Treatment Induces MRD-Negative Remission in a Pediatric B-ALL Patient With Primary Resistance to Murine-Based CD19CAR-T Therapy.

Pub. Date : 2020

PMID : 33424835






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 We further treated this patient with CD19hsCAR-T following chemotherapy with Vindesine, Idarubicin, Dexamethasone, and Pegylated Asparaginase (VDLD) plus bortezomib. Idarubicin CD19 molecule Homo sapiens